Jack Bendheim Sells 3,520 Shares of Phibro Animal Health (NASDAQ:PAHC) Stock

Phibro Animal Health Corporation (NASDAQ:PAHC) CEO Jack Bendheim sold 3,520 shares of the company’s stock in a transaction that occurred on Friday, November 7th. The shares were sold at an average price of $42.86, for a total value of $150,867.20. Following the transaction, the chief executive officer directly owned 58,880 shares of the company’s stock, valued at $2,523,596.80. This trade represents a 5.64% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

Jack Bendheim also recently made the following trade(s):

• On Monday, November 10th, Jack Bendheim sold 38,303 shares of Phibro Animal Health stock. The shares were sold at an average price of $45.29, for a total value of $1,734,742.87.
• On Tuesday, November 4th, Jack Bendheim sold 3,520 shares of Phibro Animal Health stock. The stock was sold at an average price of $43.10, for a total transaction of $151,712.00.
• On Thursday, October 30th, Jack Bendheim sold 3,520 shares of Phibro Animal Health stock. The shares were sold at an average price of $41.07, for a total value of $144,566.40.
• On Tuesday, October 28th, Jack Bendheim sold 3,520 shares of Phibro Animal Health stock. The shares were sold at an average price of $41.56, for a total value of $146,291.20.
• On Thursday, October 23rd, Jack Bendheim sold 3,520 shares of Phibro Animal Health stock. The stock was sold at an average price of $40.18, for a total transaction of $141,433.60.
• On Wednesday, October 22nd, Jack Bendheim sold 11,859 shares of Phibro Animal Health stock. The shares were sold at an average price of $40.27, for a total value of $477,561.93.
• On Monday, October 20th, Jack Bendheim sold 16,075 shares of Phibro Animal Health stock. The stock was sold at an average price of $40.38, for a total value of $649,108.50.
• On Friday, October 17th, Jack Bendheim sold 700 shares of Phibro Animal Health stock. The shares were sold at an average price of $40.03, for a total value of $28,021.00.
• On Thursday, September 18th, Jack Bendheim sold 7,022 shares of Phibro Animal Health stock. The shares were sold at an average price of $40.26, for a total value of $282,705.72.
• On Wednesday, September 10th, Jack Bendheim sold 3,520 shares of Phibro Animal Health stock. The shares were sold at an average price of $41.29, for a total value of $145,340.80.

Phibro Animal Health Stock Up 4.7%

Shares of NASDAQ:PAHC traded up $2.07 during trading on Monday, reaching $45.83. 462,658 shares of the company traded hands, compared to its average volume of 278,152. The company has a quick ratio of 1.25, a current ratio of 2.76 and a debt-to-equity ratio of 2.46. Phibro Animal Health Corporation has a 1-year low of $16.16 and a 1-year high of $46.42. The firm has a fifty day simple moving average of $39.89 and a 200 day simple moving average of $31.24. The firm has a market cap of $1.86 billion, a P/E ratio of 38.84, a price-to-earnings-growth ratio of 1.24 and a beta of 0.81.

Phibro Animal Health (NASDAQ:PAHC) last released its earnings results on Wednesday, November 5th. The company reported $0.73 earnings per share for the quarter, topping analysts’ consensus estimates of $0.58 by $0.15. The firm had revenue of $363.89 million during the quarter, compared to analyst estimates of $345.44 million. Phibro Animal Health had a net margin of 3.73% and a return on equity of 32.14%. Phibro Animal Health has set its FY 2026 guidance at 2.640-2.810 EPS. Analysts anticipate that Phibro Animal Health Corporation will post 1.95 earnings per share for the current fiscal year.

Phibro Animal Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 17th. Shareholders of record on Wednesday, November 26th will be issued a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a yield of 1.0%. The ex-dividend date of this dividend is Wednesday, November 26th. Phibro Animal Health’s payout ratio is presently 28.92%.

Institutional Trading of Phibro Animal Health

Institutional investors have recently made changes to their positions in the business. EverSource Wealth Advisors LLC increased its stake in Phibro Animal Health by 55.6% in the 3rd quarter. EverSource Wealth Advisors LLC now owns 4,233 shares of the company’s stock valued at $171,000 after buying an additional 1,513 shares during the last quarter. Advisors Preferred LLC bought a new stake in Phibro Animal Health during the third quarter worth about $3,953,000. Citigroup Inc. grew its stake in Phibro Animal Health by 112.3% in the third quarter. Citigroup Inc. now owns 54,941 shares of the company’s stock valued at $2,223,000 after purchasing an additional 29,066 shares in the last quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management increased its position in shares of Phibro Animal Health by 27.7% during the 3rd quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 14,720 shares of the company’s stock worth $596,000 after purchasing an additional 3,190 shares during the last quarter. Finally, Jupiter Asset Management Ltd. bought a new stake in shares of Phibro Animal Health during the 3rd quarter worth approximately $228,000. Institutional investors own 99.34% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages have weighed in on PAHC. Morgan Stanley set a $34.00 price target on Phibro Animal Health in a research report on Thursday, August 28th. Bank of America upped their price target on shares of Phibro Animal Health from $19.00 to $27.00 and gave the stock an “underperform” rating in a research report on Friday, August 29th. Zacks Research raised Phibro Animal Health from a “hold” rating to a “strong-buy” rating in a research note on Monday, September 29th. JPMorgan Chase & Co. raised their target price on shares of Phibro Animal Health from $45.00 to $50.00 and gave the company an “overweight” rating in a research note on Friday. Finally, Weiss Ratings upgraded shares of Phibro Animal Health from a “hold (c+)” rating to a “buy (b-)” rating in a report on Wednesday, November 5th. One research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, three have issued a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $31.40.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.